IRCT2013082513828N2CompletedPhase 2
Comparison of Dabigatran and Enoxaparin in prophylaxy of Thromboembolic events in patient with total knee replacement surgery in Shariati hospital in 1392
?Soicial Security Insurance Office/ Shariati Hospital0 sites90 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 90
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 70 years (—)
- Sex
- All
Inclusion Criteria
- •Patients who are candidate for total knee replacement(TKR)in shariati hospital
- •Age more than 18 years
- •patient's content
- •Exclusion criteria:History of:
- •Bleeding disorder, Recent stroke, Major surgery,trauma,Myocardial
- •infarction,Uncontrolled Hypertension in recent 3 months,Liver or GI disease,GI or
- •GU bleeding in recent 6 months,Use of NSAIDs in recent week,active malignancy,
- •Thrombocytopnia,Contrast over sensitivity,Renal failure
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 4
A comparison of Dabigatran, Enoxaparin and Rivaroxaban for venous thromboembolism prophylaxisCondition 1: Deep vein thromboembolism. Condition 2: Malignant neoplasm of lower respiratory tract.Acute embolism and thrombosis of deep veins of lower extremityMalignant neoplasm of lower respiratory tract, part unspecifiedI82.4C39.9IRCT20200407046984N1Semnan University of Medical Sciences57
Recruiting
Phase 3
Prophylactic vs. therapeutic enoxaparin in severe COVID-19IRCT20220412054515N1Tehran University of Medical Sciences220
Active, not recruiting
Phase 1
Phenprocoumon versus Dabigatran in subjects with atrial fibrillation and left atrial thrombus - a prospective, randomized, controlled, open-label one year follow-up pilot studyEUCTR2014-002236-14-DEniversity Hospital Ulm40
Recruiting
Phase 3
The effectiveness of enoxaparin in preventing deep vein thrombosisDeep vein thrombosis.Phlebitis and thrombophlebitis of other deep vessels of lower extremitiesI80.2IRCT20210602051484N1Zanjan University of Medical Sciences200
Completed
Phase 2
Evaluation of the Enoxaparin in the Prophylaxis of Deep Venous ThrombosisIRCT20130917014693N11Shahid Beheshti University of Medical Sciences60